Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

The prognostic effect of weight loss prior to chemotherapy was analyzedusing data from 3,047 patients enrolled in 12 chemotherapy protocols of the Eastern Cooperative Oncology Group. The frequency of weight loss ranged from 31 percent for favorable non-Hodgkin's lymphoma to 87 percent in gastric cancer. Median survival was significantly shorter in nine protocols for the patients with weight loss compared to the patients with no weight loss. Chemotherapy response rates were lower in the patients with weight loss, but only in patients with breast cancer was this difference significant. Decreasing weight was correlated with decreasing performance status except for patients with pancreatic and gastric cancer. Within performance status categories, weight loss was associated with decreased median survival. The frequency of weight loss increased with increasing number of anatomic sites involved with metastases, but within categories of anatomic involvement, weight loss was associated with decreased median survival. These observations emphasize the prognostic effect of weight loss, especially in patients with a favorable performance status or a limited anatomic involvement with tumor.

[1]  W. Dewys.  A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide. , 1972, Cancer research.

[2]  G. Murphy.  Roswell Park Memorial Institute , 1980 .

[3]  M. Tubiana,et al.  Prognostic factors in 454 cases of Hodgkin's disease. , 1971, Cancer research.

[4]  R. Hartsock,et al.  Eastern cooperative oncology group experience with the rappaport classification of non‐Hodgkin's lymphomas , 1979, Cancer.

[5]  Alford Tc.  CHEMOTHERAPY OF DISSEMINATED BREAST CANCER. , 1963 .

[6]  E. Gehan,et al.  Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria , 1977, Cancer.

[7]  J. Holm,et al.  Skeletal muscle metabolism in patients with malignant tumor. , 1976, European journal of cancer.

[8]  R. Gelber,et al.  Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". , 1979, Surgery.

[9]  M. Tubiana,et al.  Kinetics of cell proliferation of an experimental tumor. , 1967, Cancer research.

[10]  P. Band,et al.  Chemotherapy of disseminated breast cancer: Current status and prospects , 1977, Cancer.

[11]  R. Livingston,et al.  Principles of cancer treatment , 1982 .

[12]  T. Scherstén,et al.  Energy balance and body composition in cancer patients. , 1978, Cancer research.

[13]  M. Zelen.  Keynote address on biostatistics and data retrieval. , 1973, Cancer chemotherapy reports. Part 3.

[14]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[15]  W. Dewys.  Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. , 1972, Cancer research.

[16]  E. Henderson.  Treatment of acute leukemia. , 1969, Seminars in hematology.

[17]  W. Dewys,et al.  Abnormalities of taste sensation in cancer patients , 1975, Cancer.

[18]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[19]  W. R. Bruce,et al.  Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to 5-fluorouracil. , 1967, Journal of the National Cancer Institute.

[20]  M. S. Tobin,et al.  Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non‐lymphocytic leukemia in adults , 1980, Cancer.

[21]  Fenninger Ld,et al.  Energy and nitrogen metabolism in cancer. , 1954 .

[22]  A. Terepka,et al.  Metabolic observations during the forced feeding of patients with cancer. , 1956, The American journal of medicine.

[23]  A. Keys,et al.  DENSITOMETRIC ANALYSIS OF BODY COMPOSITION: REVISION OF SOME QUANTITATIVE ASSUMPTIONS * , 1963, Annals of the New York Academy of Sciences.

[24]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[25]  E. Copeland,et al.  Nutrition as an adjunct to cancer treatment in the adult. , 1977, Cancer research.

[26]  P. Lavin,et al.  Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5‐fluorouracil, alone or in combination with cyclophosphamide or 6‐thioguanine, with intravenous 5‐fluorouracil or beta‐2′‐deoxythioguanosine or with oral 3(4‐methyl‐cyclohexyl)‐1(2‐chlorethyl)‐1‐nitrosourea. A phase II‐III stu , 1978, Cancer.

[27]  P. Lavin,et al.  Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group report , 1980, Cancer.

[28]  W. Dewys.  Anorexia as a general effect of cancer , 1979, Cancer.

[29]  D. Byar,et al.  Results of a E.O.R.T.C. Randomized trial of cyclophosphamide and radiotherapy in inoperable lung cancer: prognostic factors and treatment results. , 1978, European journal of cancer.

[30]  W. R. Bruce,et al.  Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine. , 1967, Journal of the National Cancer Institute.